Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 53147-53148 [2013-20973]
Download as PDF
<![CDATA[
53147
Federal Register / Vol. 78, No. 167 / Wednesday, August 28, 2013 / Notices
Comments on the ICR must be
received on or before October 28, 2013.
ADDRESSES: Submit your comments to
Information.CollectionClearance@
hhs.gov or by calling (202) 690–6162.
FOR FURTHER INFORMATION CONTACT:
Information Collection Clearance staff,
Information.CollectionClearance@
hhs.gov or (202) 690–6162.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the
document identifier HHS–OS–0990–
0317–60D for reference.
Information Collection Request Title:
HHS Supplemental Form to the SF–424
(HHS 5161–1)
OMB No.: 0990–0317.
Abstract: HHS is requesting clearance
for the Checklist and Program Narrative
& the Public Health System Impact
Statement (PHSIS), used by several
former PHS agencies within HHS; CDC
0.1113 supplemental forms used
DATES:
exclusively by CDC; a supplement form
used exclusively by Substance Abuse
Mental Health Services Administration
(SAMHSA), and the Single Source
Agency (SSA) notification form, as well
as continued use of the project abstract
form. In addition, HHS will continue to
include the use of the 5161–1 form for
several emergency acts and funding that
were the result of the September 11th
attack on the World Trade Center,
specifically, the Public Health
Preparedness for Response to
Bioterrorism (Emergency Supplement)
(CDC), the Bioterrorism Hospital
Preparedness Program cooperative
agreement (HRSA), and 2 emergency
response grants from (SAMHSA).
Need and Proposed Use of the
Information: Each agency’s financial
assistance program evaluates the
information provided by the applicants
to select the ones most likely to meet
program objectives and to determine
No. of
respondents
Forms
that satisfactory progress is being made
on funded projects.
Likely Respondents: CDC, SAMHSA,
IHS, OS, FDA, and HRSA
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions, to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information, to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information, and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
Response per
respondent
Avg. burden
per response
(in hours)
Total burden
(in hours)
Program Narrative, Checklist, & Project Abstract ...........................................
Program Narrative, Checklist & Project Narrative (CDC) ................................
Program Narrative, Checklist, & Project Narrative (HRSA) ............................
CDC Form 0.1113 ...........................................................................................
Public Health Impact Statement (PHSIS) ........................................................
7,338
59
59
1,000
2,845
1
6
1
1
2.5
4
24
50
30/60
10/60
29,373
8,496
2,950
500
1,185
Total ..........................................................................................................
........................
........................
........................
42,691
OS specifically requests comments on
(1) The necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Darius Taylor,
Deputy Information Collection Clearance
Officer.
[FR Doc. 2013–20959 Filed 8–27–13; 8:45 am]
wreier-aviles on DSK5TPTVN1PROD with NOTICES
BILLING CODE 4151–17–P
VerDate Mar<15>2010
15:21 Aug 27, 2013
Jkt 229001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC)
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Advisory Board on Radiation and
Worker Health: Notice of Charter
Renewal
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the
Advisory Board on Radiation and
Worker Health, Department of Health
and Human Services, has been renewed
for a 2-year period through August 3,
2015.
For Further Information Contact: Mr.
Theodore Katz, Designated Federal
Officer, Advisory Board on Radiation
and Worker Health, Department of
Health and Human Services, 1600
Clifton Road, M/S E20, Atlanta, Georgia,
30341, telephone 404/498–2533, or fax
404/498–2570.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
[FR Doc. 2013–20974 Filed 8–27–13; 8:45 am]
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
E:\FR\FM\28AUN1.SGM
28AUN1
wreier-aviles on DSK5TPTVN1PROD with NOTICES
53148
Federal Register / Vol. 78, No. 167 / Wednesday, August 28, 2013 / Notices
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 10:00 a.m.–5:00 p.m.,
September 30, 2013.
Place: Audio Conference Call via FTS
Conferencing. The USA toll-free, dial-in
number is 1–866–659–0537 and the pass
code is 9933701.
Status: Open to the public, but
without a public comment period. To
access by conference call dial the
following information 1(866) 659–0537,
Participant Pass Code 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
and will expire on August 3, 2015.
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class. The
Subcommittee for Dose Reconstruction
Reviews was established to aid the
Advisory Board in carrying out its duty
to advise the Secretary, HHS, on dose
reconstruction.
VerDate Mar<15>2010
15:21 Aug 27, 2013
Jkt 229001
Matters to Be Discussed: The agenda
for the Subcommittee meeting includes:
dose reconstruction program quality
management and assurance activities,
including: current findings from NIOSH
internal dose reconstruction blind
reviews; and discussion of dose
reconstruction cases under review (set
9, and Rocky Flats Plant, Los Alamos
National Laboratory, and Paducah and
Portsmouth Gaseous Diffusion Plants
cases from sets 10–13).
The agenda is subject to change as
priorities dictate.
In the event an individual cannot
attend, written comments may be
submitted. Any written comments
received will be provided at the meeting
and should be submitted to the contact
person below well in advance of the
meeting.
Contact Person for More Information:
Theodore Katz, Designated Federal
Official, NIOSH, CDC, 1600 Clifton
Road, Mailstop E–20, Atlanta, Georgia
30333, Telephone (513) 533–6800, Toll
Free 1(800) CDC–INFO, Email ocas@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2013–20973 Filed 8–27–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Health Statistics
(NCHS), Classifications and Public
Health Data Standards Staff,
Announces the Following Meeting
Name: ICD–9–CM Coordination and
Maintenance (C&M) Committee meeting.
Time and Date: 9:00 a.m.–5:00 p.m.,
September 18–19, 2013.
Place: Centers for Medicare and
Medicaid Services (CMS) Auditorium,
7500 Security Boulevard, Baltimore,
Maryland 21244.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 240
people. We will be broadcasting the
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
meeting live via Webcast at hhtp://
www.cms.gov/live/.
Security Considerations: Due to
increased security requirements CMS
has instituted stringent procedures for
entrance into the building by nongovernment employees. Attendees will
need to present valid government-issued
picture identification, and sign-in at the
security desk upon entering the
building. Attendees who wish to attend
the September 18–19, 2013, ICD–9–CM
C&M meeting must submit their name
and organization by September 6, 2013,
for inclusion on the visitor list. This
visitor list will be maintained at the
front desk of the CMS building and used
by the guards to admit visitors to the
meeting.
Participants who attended previous
ICD–9–CM C&M meetings will no longer
be automatically added to the visitor
list. You must request inclusion of your
name prior to each meeting you wish
attend.
Please register to attend the meeting
on-line at: https://www.cms.hhs.gov/
apps/events/.
Please contact Mady Hue (410–786–
4510 or Marilu.hue@cms.hhs.gov), for
questions about the registration process.
Purpose: The ICD–9–CM Coordination
and Maintenance (C&M) Committee is a
public forum for the presentation of
proposed modifications to the
International Classification of Diseases,
Ninth Revision, Clinical Modification,
the International Classification of
Diseases, Tenth Revision, Clinical
Modification and ICD–10-Procedure
Coding System.
Matters To Be Discussed: Agenda
items include: September 18–19, 2013.
ICD–10 Topics:
Insertion of bone graft
Implantation of neurostimulation device
ICD–10 Updates
ICD–10–CM Diagnosis Topics:
Gastrointestinal Stromal Tumors
Hearing Loss
Low lying placenta
Mental and Behavioral disorders
Neurology topics
Observation and evaluation for
newborns
Oromaxillofacial Disorders
Pediatric topics
Periorbital and Preseptal Cellulitis
Periprosthetic Fractures
Traumatic Brain Injury
Unintended awareness under general
anesthesia
Vaccine and prophylactic
immunotherapy administration ICD–
10–CM Addendum
Agenda items are subject to change as
priorities dictate.
Note: CMS and NCHS will no longer
provide paper copies of handouts for the
E:\FR\FM\28AUN1.SGM
28AUN1
]]>Agencies
[Federal Register Volume 78, Number 167 (Wednesday, August 28, 2013)]
[Notices]
[Pages 53147-53148]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-20973]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory
Board on Radiation and Worker Health (ABRWH or the Advisory Board),
National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease
[[Page 53148]]
Control and Prevention (CDC), announces the following meeting for the
aforementioned subcommittee:
Time and Date: 10:00 a.m.-5:00 p.m., September 30, 2013.
Place: Audio Conference Call via FTS Conferencing. The USA toll-
free, dial-in number is 1-866-659-0537 and the pass code is 9933701.
Status: Open to the public, but without a public comment period. To
access by conference call dial the following information 1(866) 659-
0537, Participant Pass Code 9933701.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines that have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule; advice on methods of dose reconstruction, which have
also been promulgated by HHS as a final rule; advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program; and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2015.
Purpose: The Advisory Board is charged with (a) providing advice to
the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class. The Subcommittee
for Dose Reconstruction Reviews was established to aid the Advisory
Board in carrying out its duty to advise the Secretary, HHS, on dose
reconstruction.
Matters to Be Discussed: The agenda for the Subcommittee meeting
includes: dose reconstruction program quality management and assurance
activities, including: current findings from NIOSH internal dose
reconstruction blind reviews; and discussion of dose reconstruction
cases under review (set 9, and Rocky Flats Plant, Los Alamos National
Laboratory, and Paducah and Portsmouth Gaseous Diffusion Plants cases
from sets 10-13).
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may be
submitted. Any written comments received will be provided at the
meeting and should be submitted to the contact person below well in
advance of the meeting.
Contact Person for More Information: Theodore Katz, Designated
Federal Official, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20,
Atlanta, Georgia 30333, Telephone (513) 533-6800, Toll Free 1(800) CDC-
INFO, Email ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2013-20973 Filed 8-27-13; 8:45 am]
BILLING CODE 4163-18-P
